Cachet Pharmaceutical Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Cachet Pharmaceutical Co., Ltd. carries a market capitalization of 3.33B, placing it among publicly traded companies globally. Its enterprise value stands at 5.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.33B |
| Enterprise Value | 5.91B |
Share Statistics
Cachet Pharmaceutical Co., Ltd. currently has 291.71M shares outstanding.
| Shares Outstanding | 291.71M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Cachet Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 39.68. The price-to-sales ratio is 0.18, and the price-to-book ratio stands at 1.35.
| PE Ratio | 39.68 |
| PS Ratio | 0.18 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | 245.38 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Cachet Pharmaceutical Co., Ltd. trades at an EV/EBITDA multiple of 8.38 and an EV/FCF ratio of 376.06. The EV/Sales ratio of 0.28 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.38 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.28 |
| EV / EBITDA | 8.38 |
| EV / EBIT | 8.38 |
| EV / FCF | 376.06 |
Financial Position
Cachet Pharmaceutical Co., Ltd. maintains a current ratio of 1.78, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.78 |
| Quick Ratio | 0.33 |
| Debt / Equity | 40.34 |
| Debt / EBITDA | 3.54 |
| Interest Coverage | N/A |
Financial Efficiency
Cachet Pharmaceutical Co., Ltd. posts a return on equity of 3.42 and a return on invested capital of 4.56.
| Return on Equity (ROE) | 3.42 |
| Return on Assets (ROA) | 0.70 |
| Return on Invested Capital (ROIC) | 4.56 |
| Return on Capital Employed (ROCE) | -0.43 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.65 |
Taxes
Over the trailing twelve months, Cachet Pharmaceutical Co., Ltd. has paid 168.21M in income taxes, reflecting an effective tax rate of 42.61.
| Income Tax | 168.21M |
| Effective Tax Rate | 42.61 |
Stock Price Statistics
Cachet Pharmaceutical Co., Ltd.'s stock has declined approximately -15.3447% over the past 52 weeks. The 50-day moving average sits at 13.24, while the 200-day moving average is 14.62.
| Beta (5Y) | N/A |
| 52-Week Price Change | -15.3447% |
| 50-Day Moving Average | 13.24 |
| 200-Day Moving Average | 14.62 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Cachet Pharmaceutical Co., Ltd. generated 20.88B in revenue and converted that into 97.18M in net income, yielding earnings per share of 0.79. EBITDA reached 704.83M, while operating income came in at 704.83M.
| Revenue | 20.88B |
| Gross Profit | 1.42B |
| Operating Income | 704.83M |
| Pretax Income | 394.74M |
| Net Income | 97.18M |
| EBITDA | 704.83M |
| EBIT | 704.83M |
| Earnings Per Share (EPS) | 0.79 |
Balance Sheet
Cachet Pharmaceutical Co., Ltd. holds 2.23B in cash and equivalents against 2.49B in total debt, resulting in a net debt position of 94.74M. Total book value stands at 2.86B, with working capital of 5.31B providing operational flexibility.
| Cash & Cash Equivalents | 2.23B |
| Total Debt | 2.49B |
| Net Debt | 94.74M |
| Equity (Book Value) | 2.86B |
| Book Value Per Share | 9.93 |
| Working Capital | 5.31B |
Cash Flow
After subtracting -15.72M in capital expenditures, free cash flow totaled -15.72M - equivalent to -0.05 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -15.72M |
| Free Cash Flow | -15.72M |
| FCF Per Share | -0.05 |
Margins
Cachet Pharmaceutical Co., Ltd. operates with a gross margin of 6.80, reflecting its pricing power and cost economics. The operating margin of 3.38 and net profit margin of 0.47 provide insight into operational efficiency.
| Gross Margin | 6.80 |
| Operating Margin | 3.38 |
| Pretax Margin | 1.89 |
| Profit Margin | 0.47 |
| EBITDA Margin | 3.38 |
Dividends & Yields
The company's payout ratio of 36.43 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.45 |
| Dividend Yield | N/A |
| Payout Ratio | 36.43 |
| Shareholder Yield | 17.43 |
| FCF Yield | 0.41 |
Stock Splits
Cachet Pharmaceutical Co., Ltd.'s most recent stock split took place on July 4, 2011 with a 2:3 split ratio.
| Last Split Date | 7/4/2011 |
| Split Ratio | 2:3 |
Scores
Cachet Pharmaceutical Co., Ltd. posts an Altman Z-Score of 2.94, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.94 |